Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 28, 2027-2031, October 1, 1968]
© 1968 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Card, R. T.
Right arrow Articles by Valberg, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Card, R. T.
Right arrow Articles by Valberg, L. S.

The Effect of Hydroxyurea on Erythropoiesis, Erythrocyte Survival, and Erythrokinetics in the Rabbit1

Robert T. Card2, J. D. Lee, M. McGrath and Leslie S. Valberg

Department of Medicine, Queen's University, and The Special Investigation Unit, Kingston General Hospital, Kingston, Ontario, Canada

In a study of the effect of the administration of hydroxyurea in doses of 100–200 mg/kg/day on erythropoiesis, erythrocyte survival, and erythrokinetics, 10 of 12 rabbits developed a normocytic anemia, a decrease in plasma iron transport rate, and a reduction in red cell iron uptake, but no significant change in erythrocyte survival. The anemia was reversible and prompt recovery occurred when the drug was stopped. In 2 animals the anemia was associated with a moderate shortening of erythrocyte survival without a reduction in the plasma iron transport rate or the red cell iron uptake. In animals with phenylhydrazine-induced hemolytic anemia, hydroxyurea in a dose of 200 mg/kg/day impaired erythropoiesis, but it did not block the production of macrocytic erythrocytes in response to the erythropoietic stress.

1 Supported by a grant from The Medical Research Council of Canada and the Clare Nelson Bequest.

2 Research Fellow, Medical Research Council of Canada.

Received 3/11/68. Accepted 5/ 6/68.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1968 by the American Association for Cancer Research.